Beta-lactoglobulin 3D structures: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 23: | Line 23: | ||
**[[7bf7]], [[7bf8]], [[7bf9]] - bBlac (mutant) + tetracaine<br /> | **[[7bf7]], [[7bf8]], [[7bf9]] - bBlac (mutant) + tetracaine<br /> | ||
**[[5y5c]] – bBlac + hexanoic acid derivative<br /> | **[[5y5c]] – bBlac + hexanoic acid derivative<br /> | ||
**[[3nq3]], [[3nq9]], [[3uex]] – bBlac + fatty acid | **[[3nq3]], [[3nq9]], [[3ueu]], [[3uev]], [[3uex]], [[4dq3]], [[4dq4]], [[4ib6]], [[5lke]], [[5lkf]] – bBlac + fatty acid | ||
**[[5htd]], [[6rwp]], [[6rwq]], [[6rwr]], [[7zlf]] - bBlac (mutant) + fatty acid | |||
**[[7er3]] – bBlac + chloroquine<br /> | **[[7er3]] – bBlac + chloroquine<br /> | ||
**[[5io6]], [[5io7]] - bBlac + dodecane<br /> | **[[5io6]], [[5io7]] - bBlac + dodecane<br /> | ||
**[[ | **[[5nuj]], [[5nuk]], [[5num]], [[5nun]], [[7q19]], [[7q2n]], [[7q2o]], [[7q2p]] - bBlac (mutant) + drug<br /> | ||
**[[1gx9]], [[1gx8]] – bBlac + retinoic acid<br /> | **[[1gx9]], [[1gx8]] – bBlac + retinoic acid<br /> | ||
**[[1gxa]] - bBlac + retinoic acid + palmitate<br /> | **[[1gxa]] - bBlac + retinoic acid + palmitate<br /> | ||
Line 41: | Line 37: | ||
**[[2r56]] – bBlac + antibody<br /> | **[[2r56]] – bBlac + antibody<br /> | ||
**[[4y0p]], [[4y0q]], [[4y0r]] - bBlac + local anaesthetic<br /> | **[[4y0p]], [[4y0q]], [[4y0r]] - bBlac + local anaesthetic<br /> | ||
**[[7z9z]], [[7za0]], [[7zcd]] – bBlac (mutant) + anesthetic<br /> | |||
**[[4y0s]] - gBlac + local anaesthetic<br /> | **[[4y0s]] - gBlac + local anaesthetic<br /> | ||
**[[6t44]] - sBlac + decanoic acid derivative<br /> | **[[6t44]] - sBlac + decanoic acid derivative<br /> | ||